Skip to main content

Table 1 Patient characteristics

From: Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses

 

Rheumatoid arthritis patients

Healthy controls

Number

48

33

Age

56 ± 13

43 ± 13

% female

75

43

Disease duration (years)

12 ± 10

–

Cyclic citrullinated peptide IgG (units)

232 ± 397

–

Rheumatoid factor (IU/ml)

133 ± 236

–

C-reactive protein (mg/dl)

1 ± 1.75

–

Disease activity score

3.1 ± 1.5

–

DMARDs (%)

92%

–

TNFα inhibitors (%)

54%

–

Prednisone (%)

23%

–

  1. DMARD, disease-modifying anti-rheumatic drug; TNF, tumor necrosis factor.